Description

FOXO4-DRI, commonly referred to as a modified peptide studied in senescence related research, is investigated in laboratory environments for its involvement in cellular signaling pathways associated with aging biology, apoptotic regulation, and transcription factor interactions. Researchers explore it in experimental models related to cellular senescence, regulatory protein signaling, and longevity associated biological processes.

This product is supplied strictly for laboratory and research use only and is not intended for human or veterinary administration.

Key Research Areas:
• Cellular senescence and aging biology models
• Apoptotic signaling pathways
• Transcription factor interaction research
• Longevity related biological studies

Quality Commitment:
Each vial is produced to high analytical standards and supported by third party testing for identity and purity to ensure reliability in experimental environments.